GROSSMAN, TAMAR R.,MCCALEB, MICHAEL L.,WATT, ANDREW T.,FREIER, SUSAN M.
申请号：
PL14844168
公开号：
PL3043827T3
申请日:
2014.09.12
申请国别(地区):
PL
年份:
2020
代理人:
摘要：
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.
